Abstract
For this study, we investigated comprehensive expression of conjoined genes (CGs) in non-Hodgkin B-cell lymphoma (B-NHL) cell line KPUM-UH1 by using paired-end RNA sequencing. Furthermore, we analyzed the expression of these transcripts in an additional 21 cell lines, 37 primary samples of various malignancies and peripheral blood mononuclear cells of four normal individuals. Seventeen CGs were detected in KPUM-UH1: CTBS-GNG5, SRP9-EPHX1, RMND5A-ANAPC, OTX1-EHBP1, ATF2-CHN1, PRKAA1-TTC33, LARP1-MRPL22, LOC105379697-BAK1, TIAM2-SCAF8, SPAG1-VPS13B, WBP1L-CNNM2, NARS2-GAB2, CTSC-RAB38, VAMP1-CD27-AS1, LRRC37A2-NSF, UBA2-WTIP and ZNF600-ZNF611. To our knowledge, 10 of these genes have not been previously reported. The various characteristics of the CGs included in- and out-of-frame fusions, chimeras involving non-coding RNA and transcript variants. A finding of note was that LARP1-MRPL2 was characterized as in-frame fusion and was recurrently expressed in B-NHL samples. In this study, variety of CGs was expressed both in malignant and normal cells, some of which might be specific to lymphoma.
Keywords
LARP1
MRPL2
Conjoined genes
non-Hodgkin B-cell lymphoma
MeSH 主题词
Base Sequence
Cell Line, Tumor
Gene Dosage
Humans
Lymphoma, B-Cell/genetics
Oncogene Fusion
Oncogene Proteins, Fusion/genetics
Sequence Analysis, RNA
Tumor Cells, Cultured
化学物质
Oncogene Proteins, Fusion
作者与单位
共 14 位作者,点击展开单位 / ORCID
Matsumoto Yosuke
Department of Hematology, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan.
Tsukamoto Taku
Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Chinen Yoshiaki
Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan. | Department of Hematology, Fukuchiyama City Hospital, Fukuchiyama, Japan.
Shimura Yuji
Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Sasaki Nana
Department of Hematology, Japanese Red Cross Kyoto Daini Hospital, Kyoto, Japan.
Nagoshi Hisao
Department of Hematology and Oncology, Hiroshima University, Hiroshima, Japan.
Sato Ryuichi
Department of Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Adachi Hiroko
Department of Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Nakano Masakazu
Department of Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Horiike Shigeo
Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Kuroda Junya
Division of Hematology and Oncology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Taki Tomohiko
Department of Medical Technology, Kyorin University Faculty of Health Science, Tokyo, Japan.
Tashiro Kei
Department of Genomic Medical Sciences, Kyoto Prefectural University of Medicine, Kyoto, Japan.
Taniwaki Masafumi
Center for Molecular Diagnostics and Therapeutics, Kyoto Prefectural University of Medicine, Kyoto, Japan.